Mai Peptide
Tesamorelin
Finnrick tested 4 samples of Tesamorelin from Mai Peptide between 6 Dec 2025 and 12 Mar 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
Mai Peptide
Tesamorelin
Tested 4 Samples
Last test 12 Mar 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tesamorelin tests from top-rated vendors:
All Tesamorelin tests from Mai Peptide
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
12 Mar 2026
First
6 Dec 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 12 Mar 2026 | View | 10mg | 10.4mg | +4.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 20 Feb 2026 | View | 10mg | 11.3mg | +13.0% | 99.78% | (no batch ID) | Silver Label / Silver Crimp / Black Cap | Lab E | Public | |
| 29 Jan 2026 | View | 10mg | 9.94mg | -0.6% | 99.90% | (no batch ID) | Silver Label / Silver Crimp / Black Cap | Lab E | Public | |
| 6 Dec 2025 | View | 10mg | 10.3mg | +3.0% | 99.95% | Oct 20, 2025 | No Label / Silver Crimp / Black Cap | Lab E | Public | |